Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment

Treatment of multidrug-resistant (MDR) tuberculosis with linezolid is characterized by high rates of adverse events. Evidence on therapeutic drug monitoring to predict drug toxicity is scarce. This study aimed to evaluate the association of linezolid trough concentrations with severe toxicity. We re...

Celý popis

Podrobná bibliografia

Vydané v:	Clinical infectious diseases Ročník 76; číslo 3; s. e947
Hlavní autori:	Eimer, Johannes, Fréchet-Jachym, Mathilde, Le Dû, Damien, Caumes, Eric, El-Helali, Najoua, Marigot-Outtandy, Dhiba, Mechai, Frédéric, Peytavin, Gilles, Pourcher, Valérie, Rioux, Christophe, Yazdanpanah, Yazdan, Robert, Jérôme, Guglielmetti, Lorenzo
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 08.02.2023
Predmet:	Antitubercular Agents - adverse effects Drug Monitoring Humans Linezolid - adverse effects Retrospective Studies Tuberculosis, Multidrug-Resistant - drug therapy toxicity severe adverse events linezolid multidrug-resistant tuberculosis therapeutic drug monitoring
ISSN:	1537-6591, 1537-6591
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!